Neomed Management
Late Stage
Find your way into Neomed Management
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Hardware ×1Medical Devices ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathRepligen provides bioprocessing technologies—including process intensification, tangential flow filtration, chromatography, process analytics, and single-use fluid management—for upstream and downstream biopharmaceutical workflows.
BiotechHardwareMedical DevicesLebanon, US
Tillman Gerngross(Director)Errik Anderson(Director)inWarren Kett(Executive Officer)Jon Sheller(Executive Officer)Kevin Issett(Executive Officer, Director)Kevin Isett(Executive Officer, Director)
Co-investorsOrbiMedSV Health InvestorsBorealis VenturesMithril Capital ManagementPolaris PartnersSands Capital Ventures+1 more
Exits · 1
1 acquisitionsAvitideacq. by Repligen
Frequently asked questions
- What stage does Neomed Management invest at?
- Neomed Management invests at the Late Stage stage.
Similar investors
3TS Capital Partners is a European technology-focused growth investment adviser whose advised funds provide growth capital, typically leading or co-leading substantial funding rounds for innovative tech companies primarily in the DACH, CEE and Nordic regions.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.











